مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.
Normal view MARC view ISBD view

Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. [electronic resource]

By:
  • Jiang, Xiuxian
Contributor(s):
  • Zhao, Baoguang
  • Britton, Robert
  • Lim, Lynette Y
  • Leong, Dan
  • Sanghera, Jasbinder S
  • Zhou, Bin-Bing S
  • Piers, Edward
  • Andersen, Raymond J
  • Roberge, Michel
Producer: 20050421Description: 1221-7 p. digitalISSN:
  • 1535-7163
Subject(s):
  • Antineoplastic Agents -- pharmacology
  • Catalytic Domain
  • Cell Line, Tumor
  • Checkpoint Kinase 1
  • Crystallography, X-Ray
  • Cysteine -- chemistry
  • DNA Damage
  • Dose-Response Relationship, Drug
  • G2 Phase
  • Glutamine -- chemistry
  • Glycogen Synthase Kinase 3 -- metabolism
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Imidazoles -- pharmacology
  • Indoles -- antagonists & inhibitors
  • Inhibitory Concentration 50
  • Maleimides -- antagonists & inhibitors
  • Models, Chemical
  • Models, Molecular
  • Nitrogen -- chemistry
  • Phenotype
  • Protein Binding
  • Protein Kinase C -- metabolism
  • Protein Kinase C beta
  • Protein Kinases -- metabolism
  • Protein Structure, Tertiary
  • Time Factors
In: Molecular cancer therapeutics vol. 3
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.

Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.

APA

Jiang X., Zhao B., Britton R., Lim L. Y., Leong D., Sanghera J. S., Zhou B. S., Piers E., Andersen R. J. & Roberge M. (20050421). Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. : Molecular cancer therapeutics.

Chicago

Jiang Xiuxian, Zhao Baoguang, Britton Robert, Lim Lynette Y, Leong Dan, Sanghera Jasbinder S, Zhou Bin-Bing S, Piers Edward, Andersen Raymond J and Roberge Michel. 20050421. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. : Molecular cancer therapeutics.

Harvard

Jiang X., Zhao B., Britton R., Lim L. Y., Leong D., Sanghera J. S., Zhou B. S., Piers E., Andersen R. J. and Roberge M. (20050421). Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. : Molecular cancer therapeutics.

MLA

Jiang Xiuxian, Zhao Baoguang, Britton Robert, Lim Lynette Y, Leong Dan, Sanghera Jasbinder S, Zhou Bin-Bing S, Piers Edward, Andersen Raymond J and Roberge Michel. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. : Molecular cancer therapeutics. 20050421.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site